Moreover, tumor cells engineered to lack Atg5 or to express the ATP-destroying ectoenzyme CD39 failed to respond to chemotherapy alone or in combination with aspirin even in the context of an intact immune system (Fig. 6d). Here, ENTPD1 is linked to neoplasm.